Article
HC Wainwright & Co. Maintains Buy on Nuvation Bio, Lowers Price Target to $17
HC Wainwright & Co. analyst Robert Burns maintains Nuvation Bio (NYSE:NUVB) with a Buy and lowers the price target from $18 to $17.
Comments
- No comments yet. Be the first to comment!